Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Colombo

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
British Journal of Haematology|May 15, 2009
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemiaFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
International Journal of Molecular Sciences|February 13, 2026
Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic LeukemiaMartina Cardillo, Fabiana Ferrero, Nadia Bertola, et al.
Scientific Reports|October 29, 2020
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patientsPaola Monti, Marta Lionetti, Giuseppa De Luca, et al.
Hematological Oncology|February 26, 2020
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patientsMarta Lionetti, Marzia Barbieri, Vanessa Favasuli, et al.
Hematological Oncology|August 12, 2022
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective studyGiuseppa De Luca, Giannamaria Cerruti, Sonia Lastraioli, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
Leukemia Research|June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatmentFortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
British Journal of Haematology|May 15, 2009
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemiaFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
International Journal of Molecular Sciences|February 13, 2026
Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic LeukemiaMartina Cardillo, Fabiana Ferrero, Nadia Bertola, et al.
Scientific Reports|October 29, 2020
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patientsPaola Monti, Marta Lionetti, Giuseppa De Luca, et al.
Hematological Oncology|February 26, 2020
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patientsMarta Lionetti, Marzia Barbieri, Vanessa Favasuli, et al.
Hematological Oncology|August 12, 2022
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective studyGiuseppa De Luca, Giannamaria Cerruti, Sonia Lastraioli, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
Leukemia Research|June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatmentFortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Pageof 8